Abstract
Each year 40% of the worldapos;s children are exposed to tobacco smoke and 166,000 children die from that exposure annually. The 2006 and 2010 U.S. Surgeon General Reports concluded that there is no safe level of tobacco smoke exposure (TSE). The only way to completely protect children from the dangers of household TSE is to help all household members quit. Due to the many health concerns associated with children's TSE, parental tobacco control is a priority within the pediatric setting. Child healthcare clinicians are in a unique position to influence the smoking behaviors of parents, thereby improving the health of their patients. The Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE) is a parental tobacco control intervention that uses an operational form of the U.S. Department of Health and Human Service's (HHS) Treating Tobacco Use and Dependence Guideline in the context of the child's outpatient medical visit. The CEASE method includes three steps (Ask, Assist, Refer) that encompass the goals of the 5A's (Ask, Advise, Assess, Assist, Arrange) in a simplified format, allowing for brief, tailored cessation support for the person who smokes. This paper summarizes the research on the harms of TSE and explores how child healthcare clinicians can most effectively eliminate these health risks to children by implementing CEASE. Finally, we look at legislative initiatives that clinicians can support to help protect children from the harms of TSE.
Keywords: Child healthcare clinicians, multi-unit housing, nicotine, parents, pediatrics, smoke-free, thirdhand smoke, tobacco smoke exposure
Current Pediatric Reviews
Title: Parental Tobacco Control in the Child Healthcare Setting
Volume: 7 Issue: 2
Author(s): Janelle Dempsey, Joan Friebely, Nicole Hall, Bethany Hipple, Emara Nabi and Jonathan P. Winickoff
Affiliation:
Keywords: Child healthcare clinicians, multi-unit housing, nicotine, parents, pediatrics, smoke-free, thirdhand smoke, tobacco smoke exposure
Abstract: Each year 40% of the worldapos;s children are exposed to tobacco smoke and 166,000 children die from that exposure annually. The 2006 and 2010 U.S. Surgeon General Reports concluded that there is no safe level of tobacco smoke exposure (TSE). The only way to completely protect children from the dangers of household TSE is to help all household members quit. Due to the many health concerns associated with children's TSE, parental tobacco control is a priority within the pediatric setting. Child healthcare clinicians are in a unique position to influence the smoking behaviors of parents, thereby improving the health of their patients. The Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE) is a parental tobacco control intervention that uses an operational form of the U.S. Department of Health and Human Service's (HHS) Treating Tobacco Use and Dependence Guideline in the context of the child's outpatient medical visit. The CEASE method includes three steps (Ask, Assist, Refer) that encompass the goals of the 5A's (Ask, Advise, Assess, Assist, Arrange) in a simplified format, allowing for brief, tailored cessation support for the person who smokes. This paper summarizes the research on the harms of TSE and explores how child healthcare clinicians can most effectively eliminate these health risks to children by implementing CEASE. Finally, we look at legislative initiatives that clinicians can support to help protect children from the harms of TSE.
Export Options
About this article
Cite this article as:
Dempsey Janelle, Friebely Joan, Hall Nicole, Hipple Bethany, Nabi Emara and P. Winickoff Jonathan, Parental Tobacco Control in the Child Healthcare Setting, Current Pediatric Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339611795735602
DOI https://dx.doi.org/10.2174/157339611795735602 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunosuppressive Therapies in Solid Organ Transplantation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) COVID-19: An Update on Pathogenesis and Treatment
Current Pharmaceutical Design Kinin Receptors in Vascular Biology and Pathology
Current Vascular Pharmacology HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design Green Tea Extract-Patents and Diversity of Uses
Recent Patents on Food, Nutrition & Agriculture Recent Trends in the Pharmacological Activity of Isoprenyl Phenolics
Current Medicinal Chemistry Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Single Chemical Entity Legal Highs: Assessing the Risk for Long Term Harm
Current Drug Abuse Reviews Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
Letters in Drug Design & Discovery Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Pediatric Catatonia: Updating An Old Syndrome in Young People
Current Psychiatry Reviews Screening and Structure-Activity Relationship of Potential Compounds against Proposed Targets of COVID-19 Infection
Letters in Drug Design & Discovery Patent Selections
Recent Patents on Anti-Infective Drug Discovery MiRNA-29: A microRNA Family with Tumor-Suppressing and Immune-Modulating Properties
Current Molecular Medicine Characterization of Fungal and Bacterial Components in Gut/Fecal Microbiome
Current Drug Metabolism MEMS and Microfluidics for Diagnostics Devices
Current Pharmaceutical Biotechnology Cardiovascular Diseases in Pregnancy - A Brief Overview
Current Cardiology Reviews Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design